These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2912584)

  • 1. Hydrolysis of bisphenol A diglycidylether by epoxide hydrolases in cytosolic and microsomal fractions of mouse liver and skin: inhibition by bis epoxycyclopentylether and the effects upon the covalent binding to mouse skin DNA.
    Bentley P; Bieri F; Kuster H; Muakkassah-Kelly S; Sagelsdorff P; Stäubli W; Waechter F
    Carcinogenesis; 1989 Feb; 10(2):321-7. PubMed ID: 2912584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities.
    Hammock BD; Ota K
    Toxicol Appl Pharmacol; 1983 Nov; 71(2):254-65. PubMed ID: 6636190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of mouse liver cytosolic epoxide hydrolase for K-region epoxides derived from polycyclic aromatic hydrocarbons.
    Oesch F; Golan M
    Cancer Lett; 1980 May; 9(3):169-75. PubMed ID: 7226148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the epoxy resin component 2,2-bis[4-(2,3-epoxypropoxy)phenyl]propane, the diglycidyl ether of bisphenol A (DGEBPA) in the mouse. Part II. Identification of metabolites in urine and faeces following a single oral dose of 14C-DGEBPA.
    Climie IJ; Hutson DH; Stoydin G
    Xenobiotica; 1981 Jun; 11(6):401-24. PubMed ID: 7293231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dosimetry of DNA adducts in C3H mice treated with bisphenol A diglycidylether.
    Steiner S; Hönger G; Sagelsdorff P
    Carcinogenesis; 1992 Jun; 13(6):969-72. PubMed ID: 1600618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic inactivation of five glycidyl ethers in lung and liver of humans, rats and mice in vitro.
    Boogaard PJ; de Kloe KP; Bierau J; Kuiken G; Borkulo PE; Watson WP; van Sittert NJ
    Xenobiotica; 2000 May; 30(5):485-502. PubMed ID: 10875682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of human liver cytosolic epoxide hydrolase and comparison to the microsomal enzyme.
    Wang P; Meijer J; Guengerich FP
    Biochemistry; 1982 Nov; 21(23):5769-76. PubMed ID: 6185139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human liver cytosolic epoxide hydrolases.
    Schladt L; Thomas H; Hartmann R; Oesch F
    Eur J Biochem; 1988 Oct; 176(3):715-23. PubMed ID: 3169021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates.
    Müller F; Arand M; Frank H; Seidel A; Hinz W; Winkler L; Hänel K; Blée E; Beetham JK; Hammock BD; Oesch F
    Eur J Biochem; 1997 Apr; 245(2):490-6. PubMed ID: 9151984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydration of an 18O epoxide by a cytosolic epoxide hydrolase from mouse liver.
    Hammock BD; Ratcliff M; Schooley DA
    Life Sci; 1980 Nov; 27(18):1635-41. PubMed ID: 7442462
    [No Abstract]   [Full Text] [Related]  

  • 11. Microsomal and cytosolic epoxide hydrolase in Drosophila melanogaster.
    Jansen M; Baars AJ; Breimer DD
    Biochem Pharmacol; 1986 Jul; 35(13):2229-32. PubMed ID: 3089226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of epoxide metabolism by alpha,beta-epoxyketones and isosteric analogs.
    Prestwich GD; Kuo JW; Park SK; Loury DN; Hammock BD
    Arch Biochem Biophys; 1985 Oct; 242(1):11-5. PubMed ID: 4051497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ distribution of epoxide hydrolases in cytosolic and microsomal fractions of normal and nafenopin-treated male DBA/2 mice.
    Waechter F; Bentley P; Bieri F; Muakkassah-Kelly S; Stäubli W; Villermain M
    Biochem Pharmacol; 1988 Oct; 37(20):3897-903. PubMed ID: 3190736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrolysis of the 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases.
    Luo G; Qato MK; Guenthner TM
    Drug Metab Dispos; 1992; 20(3):440-5. PubMed ID: 1521503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic epoxide hydrolase activities and their induction by clofibrate and diethylhexylphthalate in various strains of mice.
    Gill SS; Kaur S
    Biochem Pharmacol; 1987 Dec; 36(24):4221-7. PubMed ID: 3318844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K epoxide reductase activity in the metabolism of epoxides.
    Liptay-Reuter I; Dose K; Guenthner T; Wörner W; Oesch F
    Biochem Pharmacol; 1985 Aug; 34(15):2617-20. PubMed ID: 4015704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential substrate selectivity of murine hepatic cytosolic and microsomal epoxide hydrolases.
    Hammock BD; Hasagawa LS
    Biochem Pharmacol; 1983 Apr; 32(7):1155-64. PubMed ID: 6847708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct rat hepatic microsomal epoxide hydrolases catalyze the hydration of cholesterol 5,6 alpha-oxide and certain xenobiotic alkene and arene oxides.
    Levin W; Michaud DP; Thomas PE; Jerina DM
    Arch Biochem Biophys; 1983 Feb; 220(2):485-94. PubMed ID: 6401984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alphatic 3,4-epoxyalcohols. Metabolism by epoxide hydrase and mutagenic activity.
    Ortiz de Montellano PR; Boparai AS
    Biochim Biophys Acta; 1978 Dec; 544(3):504-13. PubMed ID: 728469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Hydroxyacetaminophen: a microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen.
    Hinson JA; Pohl LR; Monks TJ; Gillette JR; Guengerich FP
    Drug Metab Dispos; 1980; 8(5):289-94. PubMed ID: 6107223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.